# The Human Medicines Regulations 2012, Regulation 279: Products without a marketing authorisation etc

Extent: E+W+S+N.I.

(1) A person may not publish an advertisement in Great Britain for a medicinal product unless one of the following is in force for the product—
(a) a UKMA(GB) or UKMA(UK);
(aa) an authorisation by the licensing authority on a temporary basis under regulation 174;
(b) a COR(GB) or COR(UK); or
(c) a THR(GB) or THR(UK).
(2) A person may not publish an advertisement in Northern Ireland for a medicinal product unless one of the following is in force for the product—
(a) a UKMA(NI) or UKMA(UK);
(aa) an authorisation by the licensing authority on a temporary basis under regulation 174;
(b) a COR(NI) or COR(UK);
(c) a THR(NI) or THR(UK); or
(d) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(e) an Article 126a authorisation.
(3) A person may not publish an advertisement in the whole United Kingdom for a medicinal product unless, in relation to that product—
(a) one of the authorisations or registrations specified in paragraph (1) is in force in Great Britain; and
(b) one of the authorisations or registrations specified in paragraph (2) is in force in Northern Ireland.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/regulation/279 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/regulation-279
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.